The value of apelin-36 and brain natriuretic peptide measurements in patients with first ST-elevation myocardial infarction

Clinica Chimica Acta

Volumn 411, Issue 23-24, 2010, Pages 2014-2018

  Tycinska, Agnieszka M ^a   Sobkowicz, Bozena ^a   Mroczko, Barbara ^a   Sawicki, Robert ^a   Musial, Wlodzimierz J ^a   Dobrzycki, Slawomir ^a   Waszkiewicz, Ewa ^a   Knapp, Malgorzata A ^a   Szmitkowski, Maciej ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Apelin 36; BNP; STEMI

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; APELIN; APELIN 36; BRAIN NATRIURETIC PEPTIDE; UNCLASSIFIED DRUG;

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; DEATH; DIAGNOSTIC VALUE; DOWN REGULATION; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HOSPITALIZATION; HUMAN; MALE; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RECURRENT DISEASE; ST SEGMENT ELEVATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; UPREGULATION;

AGED; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 77957749323     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.08.024     Document Type: Article

References (15)

1. Miettinen K.H., Magga J., Vuoltenaho O., et al. Utility of plasma apelin and other indices of cardiac dysfunction in the clinical assessment of patients with dilated cardiomyopathy. Regul Pept 2007, 140:178-184.
2. de Lemos J.A., McGuire D.K., Drazner M.H. B-type natriuretic peptide in cardiovascular disease. Lancet 2003, 362:316-322.
3. Sabatine M.S., Morrow D.A., de Lemos J.A., et al. Elevation of B-type natriuretic peptide in the setting of myocardial ischemia. Circulation 2001, 104:II-485. Suppl. II:.
4. Zhang J., Ren C.X., Qi Y.F., et al. Exercise training promotes expression of apelin and APJ of cardiovascular tissues in spontaneously hypertensive rats. Life Sci 2006, 79:1153-1159.
5. Goetze J.P., Rehfeld J.F., Carlsen J., et al. Apelin: A new plasma marker of cardiopulmonary disease. Regul Pept 2006, 133:134-138.
6. Japp A.G., Newby D.E. The apelin-APJ system in heart failure: pathophysiologic relevance and therapeutic potential. Biochem Pharmacol 2008, 75:1882-1892.
7. Iwanaga Y., Kihara Y., Takenaka H., Kita T. Down-regulation of cardiac apelin system in hypertrophied and failing hearts: possible role of angiotensin II-angiotensin type 1 receptor system. J Moll Cell Cardiol 2006, 41:798-806.
8. Chong K.S., Gardner R.S., Morton J.J., Ashley E.A., McDonagh T.A. Plasma concentrations of the novel peptide apelin are decreased in patients with chronic heart failure. Eur J Heart Fail 2006, 8:355-360.
9. Francia P., Salvati A., Balla C., et al. Cardiac resynchronization therapy increases plasma levels of the endogenous inotrope apelin. Eur J Heart Fail 2007, 9:306-309.
10. Japp A.G., Cruden N.L., Amer D.A., et al. Vascular effects of apelin in vivo in man. J Am Coll Cardiol 2008, 52:908-913.
11. Güneş Y., Okçün B., Kavlak E., Erbaş C., Karcier S. Value of brain natriuretic peptide after acute myocardial infarction. Anadolu Kardiyol Derg 2008, 8:182-187.
12. Goetze J.P., Gore A., Møller C.H., Steinbrüchel D.A., Rehfeld J.F., Nielsen L.B. Acute myocardial hypoxia increases BNP gene expression. FASEB J 2004, 18:1928-1930.
13. Grewal J., McKelvie R.S., Persson H., et al. Usefulness of N-terminal pro-brain de and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction. Am J Cardiol 2008, 102:733-777.
14. Jeong Y.H., Lee S.W., Lee C.W., et al. Biomarkers on admission for the prediction of cardiovascular events after primary stenting in patients with ST-elevation myocardial infarction. Clin Cardiol 2008, 31:572-579.
15. Kuklinska A.M., Sobkowicz B., Mroczko B., et al. Prognostic significance of the admission plasma B-type natriuretic peptide measurement in patients with first ST-elevation myocardial infarction in comparison with C-reactive protein and TIMI risk score. Clin Chim Acta 2007, 382:106-111.